IE37106L - Prostaglandins - Google Patents

Prostaglandins

Info

Publication number
IE37106L
IE37106L IE730057A IE5773A IE37106L IE 37106 L IE37106 L IE 37106L IE 730057 A IE730057 A IE 730057A IE 5773 A IE5773 A IE 5773A IE 37106 L IE37106 L IE 37106L
Authority
IE
Ireland
Prior art keywords
trans
iodo
cyclopentene
och
cyclohexyl
Prior art date
Application number
IE730057A
Other versions
IE37106B1 (en
Original Assignee
Wisconsin Alumni Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/221,058 external-priority patent/US4031129A/en
Application filed by Wisconsin Alumni Res Found filed Critical Wisconsin Alumni Res Found
Priority to IE598/76A priority Critical patent/IE37107B1/en
Publication of IE37106L publication Critical patent/IE37106L/en
Publication of IE37106B1 publication Critical patent/IE37106B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/06—Aluminium compounds
    • C07F5/061—Aluminium compounds with C-aluminium linkage
    • C07F5/066—Aluminium compounds with C-aluminium linkage compounds with Al linked to an element other than Al, C, H or halogen (this includes Al-cyanide linkage)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C17/00—Preparation of halogenated hydrocarbons
    • C07C17/013—Preparation of halogenated hydrocarbons by addition of halogens
    • C07C17/02—Preparation of halogenated hydrocarbons by addition of halogens to unsaturated hydrocarbons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C17/00—Preparation of halogenated hydrocarbons
    • C07C17/093—Preparation of halogenated hydrocarbons by replacement by halogens
    • C07C17/10—Preparation of halogenated hydrocarbons by replacement by halogens of hydrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/51—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition
    • C07C45/511—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition involving transformation of singly bound oxygen functional groups to >C = O groups
    • C07C45/513—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition involving transformation of singly bound oxygen functional groups to >C = O groups the singly bound functional group being an etherified hydroxyl group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/56—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds
    • C07C45/57—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with oxygen as the only heteroatom
    • C07C45/58—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with oxygen as the only heteroatom in three-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/65—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by splitting-off hydrogen atoms or functional groups; by hydrogenolysis of functional groups
    • C07C45/66—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by splitting-off hydrogen atoms or functional groups; by hydrogenolysis of functional groups by dehydration
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/32—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by aldehydo- or ketonic radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F1/00—Compounds containing elements of Groups 1 or 11 of the Periodic Table
    • C07F1/02—Lithium compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F1/00—Compounds containing elements of Groups 1 or 11 of the Periodic Table
    • C07F1/08—Copper compounds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Materials Engineering (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

1419181 Prostaglandins; organolithium compounds WISCONSIN ALUMNI RESEARCH FOUNDATION 24 Jan 1973 [26 Jan 1972 22 May 1972 29 Sept 1972] 3660/73 Headings C2C and C2J The invention comprises a process for preparing prostaglandins of the Formula I wherein R is H, CH 3 or CH 3 CH 2 ; R<SP>1</SP> is H, C 1 -C 9 saturated hydrocarbyl, pentenyl, hexenyl or benzyl; X is H, OH, 2-tetrahydropyranyloxy, OR<SP>11</SP>, wherein R<SP>11</SP> is C 1 -C 5 hydrocarbyl or benzyl, OCOR<SP>111</SP>, wherein R<SP>111</SP> is C 1 -C 8 hydrocarbyl or benzyl, or OCH(R 1 )OR 2 , wherein R 1 and R 2 each are C 1 -C 5 hydrocarbyl; n is 0 to 5; B is -CH 2 CH 2 - or -CH=CH-; Q is OH, OCH 3 or OCH 2 CH 3 ; and the ring A is by reacting compounds of the Formula II wherein B and ring A are as defined above with the proviso that any free hydroxy groups in ring A are protected, and Q is OCH 3 or OCH 2 CH 3 with compounds of the Formula III trans-Li-CH = CH-C(R)(X<SP>1</SP>)(CH 2 ) n R<SP>1</SP> wherein X<SP>1</SP> is H or protected hydroxy as defined above, and if desired removing any protecting groups and/or ester groups, and if desired converting in known manner one ring A to another ring A, and the novel compound of the formula which are obtained by the above process. The following intermediates and starting materials are also prepared: ethyl 1,3-cyclopentadieneheptanoate, ethyl 3-hydroxy-5-oxo- 1 - cyclopentene - 1 - heptanoate ethyl 5- hydroxy - 3 - oxo - 1 - cyclopentene - 1 - heptenoate ethyl 5 - oxo - 3 - (2 - tetrahydropyranyloxy) - 1 - cyclopentene - 1 - heptanoate, ethyl 3,5 - dioxo - 1 - cyclopentene - 1 - heptanoate, isopropyl 3 - hydroxy - 5 - oxo - 1- cyclopentene - 1 - heptanoate, 1 - iodo - 4 - cyclohexyl - 1 - trans - butene, 1 - iodo - 5- cyclohexyl - 1 - trans - pentene, 1 - iodo - 6- cyclohexyl - 1 - trans - hexene, 1 - iodo - 7- cyclohexyl - 1 - trans - heptene, 1 - iodo - 8- cyclohexyl - 1 - trans - octene, 1 - iodo - 5- phenyl - 1 - trans - pentene, 1 - iodo - 6 - phenyl- 1 - trans - hexene, 1 - iodo - 7 - phenyl - 1- trans - heptene, 1 - iodo 8 - phenyl - 1 - transoctene and 1 - iodo - 9 - phenyl - 1 - transnonene. 1 - Lithio - 1 - trans - octene and 1 - lithio- 3 - (1 - ethoxyethoxy) - trans - 1 - octene are obtained by reacting lithium powder in diethyl ether with solutions of 1-iodo-1-trans-octene and the 3 -(1 - ethoxyethoxy) - 1 - iodo - 1- trans-octene respectively. Pharmaceutical compositions contain the above novel compounds and pharmaceutically acceptable carriers or diluents. The compounds possess prostaglandin-like activities. Reference has been directed by the Comptroller to Specification 1,377,258 also Reference has been directed by the Comptroller to Specifications 1,314,292, 1,314,291, 1,282,661 1,198,071, 1,097,533, 1,097,157 and 1,040,544. [GB1419181A]
IE57/73A 1972-01-26 1973-01-15 Prostaglandins and method for preparing same IE37106B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IE598/76A IE37107B1 (en) 1972-01-26 1973-01-15 Process for preparing 2-substituted-2-cyclopenten-1-ones

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US05/221,058 US4031129A (en) 1972-01-26 1972-01-26 15-Deoxy-PGE1 and method for preparing same
US25572872A 1972-05-22 1972-05-22
US29344272A 1972-09-29 1972-09-29

Publications (2)

Publication Number Publication Date
IE37106L true IE37106L (en) 1973-07-26
IE37106B1 IE37106B1 (en) 1977-05-11

Family

ID=27396893

Family Applications (2)

Application Number Title Priority Date Filing Date
IE57/73A IE37106B1 (en) 1972-01-26 1973-01-15 Prostaglandins and method for preparing same
IE599/76A IE37108B1 (en) 1972-01-26 1973-01-15 Iodo-alkenes

Family Applications After (1)

Application Number Title Priority Date Filing Date
IE599/76A IE37108B1 (en) 1972-01-26 1973-01-15 Iodo-alkenes

Country Status (17)

Country Link
JP (3) JPS5333583B2 (en)
AR (2) AR199893A1 (en)
AU (1) AU452896B2 (en)
BE (1) BE794516A (en)
BG (3) BG25206A3 (en)
CA (1) CA1014092A (en)
CH (3) CH578502A5 (en)
DD (3) DD112750A5 (en)
DE (2) DE2365513C3 (en)
ES (3) ES410962A1 (en)
FR (3) FR2181693B1 (en)
GB (3) GB1419183A (en)
IE (2) IE37106B1 (en)
IL (5) IL49286A (en)
NL (2) NL153514B (en)
RO (1) RO71588A (en)
SE (3) SE7600888L (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1018970A (en) * 1972-10-27 1977-10-11 American Home Products Corporation 15-substituted prostanoic acids
JPS5720305B2 (en) * 1973-02-28 1982-04-27
US4029693A (en) * 1975-01-20 1977-06-14 The Upjohn Company 2A,2B-Dihomo-11-deoxy-17(substituted phenyl)-18,19,20-trinor-PGE2 compounds and their corresponding esters
US4032561A (en) * 1975-05-27 1977-06-28 The Upjohn Company 17-Phenyl-18,19,20-trinor-cis-4,5-didehydro-PGF1.sub.α compounds
US4016184A (en) * 1975-09-17 1977-04-05 The Upjohn Company 9-Deoxy-9,10-didehydro-PGD1 compounds
US4365075A (en) * 1975-09-17 1982-12-21 The Upjohn Company ω-Aryl-PGD compounds
US4029814A (en) * 1975-12-29 1977-06-14 The Upjohn Company Phenyl-substituted prostaglandin-e type analogs
US4219662A (en) * 1977-02-28 1980-08-26 The Upjohn Company 11-Deoxy-17-phenyl-PGE1 analogs
AU529883B2 (en) * 1978-09-04 1983-06-23 Australian National University, The Substituted cyclopentenones

Also Published As

Publication number Publication date
CH590834A5 (en) 1977-08-31
IE37108B1 (en) 1977-05-11
GB1419183A (en) 1975-12-24
BG25206A3 (en) 1978-08-10
AU5108173A (en) 1974-07-18
DD112750A5 (en) 1975-05-05
DD108069A5 (en) 1974-09-05
IL49285A0 (en) 1976-05-31
DE2365513A1 (en) 1975-06-26
BE794516A (en) 1973-05-16
IL41305A (en) 1977-10-31
GB1419182A (en) 1975-12-24
AR200537A1 (en) 1974-11-15
SE7600888L (en) 1976-01-28
FR2181693B1 (en) 1979-01-12
NL7708070A (en) 1977-10-31
AR199893A1 (en) 1974-10-08
DE2303612B2 (en) 1977-04-07
BG25207A3 (en) 1978-08-10
BG25208A3 (en) 1978-08-10
IL49286A0 (en) 1976-05-31
AU452896B2 (en) 1974-08-30
SE7600889L (en) 1976-01-28
CH580046A5 (en) 1976-09-30
IE37108L (en) 1973-07-26
ES438595A1 (en) 1977-06-16
RO71588A (en) 1982-02-26
DE2365513B2 (en) 1978-11-16
NL7301094A (en) 1973-07-30
IE37106B1 (en) 1977-05-11
CH578502A5 (en) 1976-08-13
JPS5253840A (en) 1977-04-30
FR2272642A1 (en) 1975-12-26
ES438594A1 (en) 1977-10-16
DE2303612A1 (en) 1973-10-25
IL49285A (en) 1977-10-31
JPS4881836A (en) 1973-11-01
FR2181693A1 (en) 1973-12-07
JPS5333583B2 (en) 1978-09-14
JPS5253801A (en) 1977-04-30
DE2365927A1 (en) 1976-12-09
CA1014092A (en) 1977-07-19
SE7600890L (en) 1976-01-28
NL153514B (en) 1977-06-15
GB1419181A (en) 1975-12-24
DE2365513C3 (en) 1979-07-19
DD113214A5 (en) 1975-05-20
FR2257567B1 (en) 1978-02-03
FR2257567A1 (en) 1975-08-08
IL49286A (en) 1977-10-31
FR2272642B1 (en) 1981-08-07
ES410962A1 (en) 1977-04-01
IL41305A0 (en) 1973-03-30

Similar Documents

Publication Publication Date Title
IE37108B1 (en) Iodo-alkenes
GB1527584A (en) Pour-on formulations of anthelmintics
GB1506824A (en) Prostaglandins
GB1497218A (en) Thiaprostaglandins
GB1528074A (en) 11-deoxyprostaglandins
GB1484591A (en) Prostaglandin compositions
SE8405514D0 (en) FURYL DERIVATIVES OF 16-SUBSTITUTED PROSTAGLANDINES AND PROCEDURES FOR THEIR PREPARATION
GB1386146A (en) Cyclopentane derivatives
IE41922L (en) Pharmaceutical compositions containing bischromones
GB1382204A (en) Derivatives of beta-phenoxyethanols
GB1471070A (en) Prostenoic acid derivatives and method for preparing same
JPS5278827A (en) Preparation of ester-group-containing fluorovinyl ethers
GB1456511A (en) P-biphenylyl esters of 15-substituted-16,17,18,19,20-pentanor prostaglandins
GB1525282A (en) 16-chloroprostaglandin analogues
IE42966L (en) 8-azaprostaglandins and process for the preparation thereof.
ES418575A1 (en) Difluoromethylene substituted prostaglandin derivatives
GB1480286A (en) 11-substituted-11-deoxy-pge analogues
GB1418701A (en) Acylated derivatives of substituted piperazines and polymeric compositions stabilized thereby
GB1346953A (en) Process for the preparation of substituted carbamates
JPS5283436A (en) Preparation of intermediates for synthesis of prostaglandin
IE38889L (en) Preparation of ampicillin
GB1414383A (en) Prostatrienoic acid derivatives and process
GB1482010A (en) Prostaglandin analogues
IE38536B1 (en) Prostaglandin type compounds
GB1410854A (en) Pharmaceutically useful prostaglandin derivatives